DE2557784C2 - Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate - Google Patents
Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische PräparateInfo
- Publication number
- DE2557784C2 DE2557784C2 DE2557784A DE2557784A DE2557784C2 DE 2557784 C2 DE2557784 C2 DE 2557784C2 DE 2557784 A DE2557784 A DE 2557784A DE 2557784 A DE2557784 A DE 2557784A DE 2557784 C2 DE2557784 C2 DE 2557784C2
- Authority
- DE
- Germany
- Prior art keywords
- residue
- forskolin
- active ingredient
- benzene
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 title claims description 21
- SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 title claims description 9
- OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 title claims description 9
- 150000001875 compounds Chemical class 0.000 title description 7
- 238000000034 method Methods 0.000 title description 7
- 239000000825 pharmaceutical preparation Substances 0.000 title description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 21
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 19
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000004480 active ingredient Substances 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- 241000131459 Plectranthus barbatus Species 0.000 description 15
- 235000005320 Coleus barbatus Nutrition 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 125000004432 carbon atom Chemical group C* 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 239000003208 petroleum Substances 0.000 description 10
- 239000013543 active substance Substances 0.000 description 9
- 239000000284 extract Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 150000008282 halocarbons Chemical class 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 4
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000004215 Carbon black (E152) Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- -1 aliphatic halogenated hydrocarbon Chemical class 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- ASGJEMPQQVNTGO-UHFFFAOYSA-N benzene chloroform Chemical compound C(Cl)(Cl)Cl.C1=CC=CC=C1.C1=CC=CC=C1 ASGJEMPQQVNTGO-UHFFFAOYSA-N 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000009090 positive inotropic effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- WPUJEWVVTKLMQI-UHFFFAOYSA-N benzene;ethoxyethane Chemical compound CCOCC.C1=CC=CC=C1 WPUJEWVVTKLMQI-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 201000005857 malignant hypertension Diseases 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000003836 peripheral circulation Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2557784A DE2557784C2 (de) | 1975-12-22 | 1975-12-22 | Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate |
| DK397376A DK155330C (da) | 1975-12-22 | 1976-09-02 | FREMGANGSMAADE TIL UDVINDING AF ET FARMAKOLOGISK AKTIVT STOF MED ET SMELTEPUNKT PAA 230-232ìC OG SUMFORMLEN C22H34O7 FRA PLANTEN COLEUS FORSKOHLII |
| LU75718A LU75718A1 (enExample) | 1975-12-22 | 1976-09-03 | |
| IE1964/76A IE43545B1 (en) | 1975-09-06 | 1976-09-03 | Pharmacologically active substance obtainable from plants |
| CA260,533A CA1083589A (en) | 1975-09-06 | 1976-09-03 | Effective substance from plants belonging to the labiatae family |
| AT657276A AT362053B (de) | 1975-12-22 | 1976-09-03 | Verfahren zur isolierung einer pharmakologisch wirksamen substanz aus pflanzen, die zur labiatae-familie gehoeren |
| SE7609756A SE439877B (sv) | 1975-12-22 | 1976-09-03 | Forfarande for utvinning av en farmakologiskt aktiv substans ur en vext tillhorande familjen labiatae, nemligen coleus forskohlii |
| GB36827/76A GB1550410A (en) | 1975-09-06 | 1976-09-06 | Pharmacologically active substance obtainable from plants |
| IT26947/76A IT1065230B (it) | 1975-12-22 | 1976-09-07 | Processo per isolare una sostanza farmacologicamente attiva da piante che appartengono alla famiglia labiatae |
| IL50431A IL50431A (en) | 1975-12-22 | 1976-09-08 | Pharmacologically active 5-acetoxy-3-ethenyl dodecahydro-6,10,10b-trihydroxy-3,4,7,7,10a-pentamethyl-1h-naphtho-(2,1b)pyran-1-one obtainined from the plant coleus forkskohlii |
| ZA765378A ZA765378B (en) | 1975-12-22 | 1976-09-08 | Process for the isolation of a pharmacologically effective substance from plants belonging to the labiatae family |
| NL7609954A NL7609954A (nl) | 1975-12-22 | 1976-09-08 | Werkwijze voor het isoleren van een farmacolo- gisch actieve stof uit planten, die tot de fa- milie van de labiaten behoren. |
| JP51107339A JPS6059237B2 (ja) | 1975-12-22 | 1976-09-09 | シソ科植物からの有効物質 |
| BE171616A BE847417A (fr) | 1975-12-22 | 1976-10-19 | Substance pharmacologiquement active obtenue a partir de plantes appartenant a la famille des labiacees, sa preparation et ses applications |
| ES454286A ES454286A1 (es) | 1975-12-22 | 1976-12-16 | Procedimiento para la obtencion de una sustancia farmacolo- gicamente activa que tiene un punto de fusion de 230-232 grados c y la formula empirica c22h34o7. |
| US05/751,967 US4088659A (en) | 1975-12-22 | 1976-12-17 | Effective substance from plants belonging to the Labiatae family |
| FR7638664A FR2336138A1 (fr) | 1975-12-22 | 1976-12-22 | Substance pharmacologiquement active obtenue a partir de plantes appartenant a la famille des labiacees, sa preparation et ses applications |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2557784A DE2557784C2 (de) | 1975-12-22 | 1975-12-22 | Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2557784A1 DE2557784A1 (de) | 1977-07-07 |
| DE2557784C2 true DE2557784C2 (de) | 1986-04-17 |
Family
ID=5965159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2557784A Expired DE2557784C2 (de) | 1975-09-06 | 1975-12-22 | Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4088659A (enExample) |
| JP (1) | JPS6059237B2 (enExample) |
| AT (1) | AT362053B (enExample) |
| BE (1) | BE847417A (enExample) |
| DE (1) | DE2557784C2 (enExample) |
| DK (1) | DK155330C (enExample) |
| ES (1) | ES454286A1 (enExample) |
| FR (1) | FR2336138A1 (enExample) |
| IL (1) | IL50431A (enExample) |
| IT (1) | IT1065230B (enExample) |
| LU (1) | LU75718A1 (enExample) |
| NL (1) | NL7609954A (enExample) |
| SE (1) | SE439877B (enExample) |
| ZA (1) | ZA765378B (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751224A (en) * | 1983-07-21 | 1988-06-14 | Brown University Research Foundation | Treatment of metastasis |
| AU2690684A (en) * | 1984-02-24 | 1985-09-10 | Kenji Adachi | Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin |
| DE3502686A1 (de) * | 1985-01-26 | 1986-08-14 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung von labdan-derivaten und ihre verwendung als arzneimittel |
| DE3502685A1 (de) * | 1985-01-26 | 1986-09-04 | Hoechst Ag, 6230 Frankfurt | Forskolin, seine analoge und derivate, verfahren zu deren herstellung mittels mikrobieller umwandlungen und die anwendung dieser verbindungen als arzneimittel |
| US4963537A (en) * | 1985-03-01 | 1990-10-16 | Hoechst-Roussel Pharmaceuticals Inc. | Labdane compounds, pharmaceutical compositions and use |
| IN163242B (enExample) | 1985-05-03 | 1988-08-27 | Hoechst India | |
| AU591196B2 (en) * | 1985-11-15 | 1989-11-30 | Nippon Kayaku Kabushiki Kaisha | Novel forskolin derivatives |
| US4740522A (en) * | 1986-08-28 | 1988-04-26 | Hoechst-Roussel Pharmaceuticals Inc. | Oxolabdanes useful as pharmaceuticals for reducing intraocular pressure |
| US4978678A (en) * | 1986-11-20 | 1990-12-18 | Hoechst-Roussel Pharmaceuticals Inc. | 12-halogenated forskolin derivatives |
| US4920146A (en) * | 1986-12-29 | 1990-04-24 | Hoechst Roussel Pharmaceuticals Inc. | Carbamoyloxylabdane compounds useful in reducing intraocular pressure |
| US5646175A (en) * | 1987-12-28 | 1997-07-08 | Hoechst Marion Roussel, Inc. | Carbamoyloxylabdane compounds |
| US5302730A (en) * | 1987-06-29 | 1994-04-12 | Nippon Kayaku Kk | Process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives |
| US4909799A (en) * | 1987-09-18 | 1990-03-20 | Olav Thulesius | Methods for preventing thrombosis; and surgical implant having reduced platelet deposition characteristics |
| US4902696A (en) * | 1987-10-08 | 1990-02-20 | Hoechst-Roussel Pharmaceuticals, Inc. | Synergistic intraocular pressure lowering combinations |
| US5846992A (en) * | 1987-10-08 | 1998-12-08 | Hoechst Marion Roussel, Inc. | Synergistic intraocular pressure lowering combinations |
| US4883793A (en) * | 1988-05-09 | 1989-11-28 | Hoechst-Roussel Pharmaceuticals Inc. | Hydrazinocarbonyloxylabdanes for treating cardiac failure |
| EP0370379B1 (en) * | 1988-11-19 | 1992-09-09 | Hoechst Aktiengesellschaft | Pharmaceutical compositions comprising labdane diterpenoid derivatives and pyrimido(6,1-a) isoquinolin-4-one derivatives and their use |
| US4999351A (en) * | 1989-01-11 | 1991-03-12 | Hoechst-Roussel Pharmaceuticals, Inc. | 7-aryl and heteroaryl ethers of desacetylforskolin |
| US5177207A (en) * | 1989-01-11 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals, Inc. | 7-aryl and heteroaryl ethers of desacetylforskolin |
| US5093336A (en) * | 1989-07-06 | 1992-03-03 | Hoechat-Roussel Pharmaceuticals, Inc. | 6- and 7-deoxyforskolin and derivatives thereof |
| US5145855A (en) * | 1989-07-06 | 1992-09-08 | Hoechst Roussel Pharmaceuticals, Inc. | 6- and 7-deoxyforskolin and derivatives thereof |
| EP0447962A1 (en) * | 1990-03-17 | 1991-09-25 | Hoechst Aktiengesellschaft | Labdanes and process for their preparation |
| FR2665637B1 (fr) * | 1990-08-13 | 1993-08-06 | Lvmh Rech | Composition cosmetique ou pharmaceutique, contenant un extrait de coleus esquirolii, de coleus scutellarioides, de coleus xanthanthus ou un de leurs melanges. |
| US6268206B1 (en) | 1998-11-06 | 2001-07-31 | David Liptak | Bioremediation, detoxication and plant-growth enhancing compositions and methods of making and using such compositions |
| US20080267939A1 (en) * | 2006-09-29 | 2008-10-30 | Jose Angel Olalde Rangel | Synergistic anti-hypertensive phyto-nutraceutical composition |
| EP2424529B1 (en) * | 2009-04-30 | 2016-12-28 | Midwestern University | Novel therapeutic treatments using centhaquin |
| WO2013021399A1 (en) | 2011-08-05 | 2013-02-14 | Council Of Scientific & Industrial Research | Pi marane diterpenes from anisochilus verticillatus |
| HUE033785T2 (en) | 2012-09-14 | 2018-01-29 | Claride Pharma S R L | Composition for the prevention and treatment of acute and recurrent urinary tract infections |
| AU2014287427B2 (en) | 2013-07-08 | 2019-11-21 | Midwestern University | Compositions and methods for treating neuropsychiatric disorders using an endothelin-B receptor agonist |
| USD923470S1 (en) | 2019-07-01 | 2021-06-29 | The Procter & Gamble Company | Absorbent article package |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH503724A (de) * | 1966-05-13 | 1971-02-28 | Hoffmann La Roche | Verfahren zur Herstellung von polycyclischen Verbindungen |
| BE795525A (fr) * | 1972-02-16 | 1973-08-16 | Roure Bertrand Dupont Sa | Naphtopyrannes, leur procede de preparation et leur applications |
-
1975
- 1975-12-22 DE DE2557784A patent/DE2557784C2/de not_active Expired
-
1976
- 1976-09-02 DK DK397376A patent/DK155330C/da not_active IP Right Cessation
- 1976-09-03 SE SE7609756A patent/SE439877B/xx not_active IP Right Cessation
- 1976-09-03 AT AT657276A patent/AT362053B/de not_active IP Right Cessation
- 1976-09-03 LU LU75718A patent/LU75718A1/xx unknown
- 1976-09-07 IT IT26947/76A patent/IT1065230B/it active
- 1976-09-08 ZA ZA765378A patent/ZA765378B/xx unknown
- 1976-09-08 NL NL7609954A patent/NL7609954A/xx not_active Application Discontinuation
- 1976-09-08 IL IL50431A patent/IL50431A/xx unknown
- 1976-09-09 JP JP51107339A patent/JPS6059237B2/ja not_active Expired
- 1976-10-19 BE BE171616A patent/BE847417A/xx not_active IP Right Cessation
- 1976-12-16 ES ES454286A patent/ES454286A1/es not_active Expired
- 1976-12-17 US US05/751,967 patent/US4088659A/en not_active Expired - Lifetime
- 1976-12-22 FR FR7638664A patent/FR2336138A1/fr active Granted
Non-Patent Citations (1)
| Title |
|---|
| NICHTS-ERMITTELT |
Also Published As
| Publication number | Publication date |
|---|---|
| IL50431A0 (en) | 1976-11-30 |
| IL50431A (en) | 1980-01-31 |
| FR2336138B1 (enExample) | 1981-11-20 |
| DK397376A (da) | 1977-06-23 |
| ATA657276A (de) | 1980-09-15 |
| AT362053B (de) | 1981-04-27 |
| ES454286A1 (es) | 1978-03-16 |
| FR2336138A1 (fr) | 1977-07-22 |
| DE2557784A1 (de) | 1977-07-07 |
| ZA765378B (en) | 1977-08-31 |
| LU75718A1 (enExample) | 1977-06-15 |
| IT1065230B (it) | 1985-02-25 |
| SE7609756L (sv) | 1977-06-23 |
| NL7609954A (nl) | 1977-06-24 |
| BE847417A (fr) | 1977-04-19 |
| US4088659A (en) | 1978-05-09 |
| JPS6059237B2 (ja) | 1985-12-24 |
| SE439877B (sv) | 1985-07-08 |
| DK155330B (da) | 1989-03-28 |
| DK155330C (da) | 1989-08-14 |
| JPS5279015A (en) | 1977-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2557784C2 (de) | Forskolin, Verfahren zu dessen Gewinnung und diese Verbindung enthaltende pharmazeutische Präparate | |
| DE2640275A1 (de) | Pharmakologisch wirksame substanz aus labiaten | |
| DE10128266A1 (de) | Verfahren zur Herstellung eines Extrakts mit starker Antiinflammations-Antiblutplättchenaggregations- und Antifungi-Aktivität aus Zingiber officinale und pharmazeutische Zusammensetzungen, die diesen Extrakt enthalten | |
| DE60202603T2 (de) | 8-(c-beta-d-glucopyranosyl)-7,3',4'-trihydroxyflavone, verfahren zur isolation aus pterocarpus marsupium und pharmazeutische zusammensetzung zur behandlung von diabetes | |
| EP0192056B1 (de) | Verfahren zur Herstellung von Labdan-Derivaten und ihre Verwendung als Arzneimittel | |
| DE19750623A1 (de) | Pyranone, Verfahren zu ihrer Herstellung und Verwendung | |
| DE2330990A1 (de) | Vincaminderivate, verfahren zur herstellung von vincamin und dessen derivaten, sowie diese vincaminderivate als wirkstoff enthaltende arzneimittel | |
| DE10220149B4 (de) | Pharmazeutische Antidepressions-Zusammensetzung, die einen Polygala-Extrakt enthält | |
| DE2347576C2 (de) | Bruceantin und diese Verbindung enthaltende antileukämische Mittel | |
| DE2504045B2 (de) | 16,17 dihydro-apovincaminsaeure-2- hydroxypropylester, deren salze, verfahren zu ihrer herstellung und arzneimittel | |
| DE3025223A1 (de) | Pharmazeutische zubereitungen auf der grundlage von efeuextrakten und verfahren zu ihrer herstellung | |
| DE1642646C3 (de) | Verfahren zur Herstellung von Coenzymen Q tief 9, Q tief 11, Q tief 12 und Q tief 10 | |
| DE102007057231A1 (de) | Verwendung eines potenten Produktes, extrahiert aus Wurzelstöcken von Zingiber officinale zur Behandlung einer Krankheit, die mit Helicobacter pylori in Verbindung steht | |
| DE2846210A1 (de) | Neue antileukaemische trichothecin epoxide | |
| DE2652380A1 (de) | Verfahren zur isolation von uteroevakuierenden substanzen aus der zoapatlepflanze | |
| CA1083589A (en) | Effective substance from plants belonging to the labiatae family | |
| DE3228006A1 (de) | Neue verbindungen mit pharmakologischer wirkung und verfahren zu ihrer herstellung | |
| DE3112737C2 (enExample) | ||
| DE2723225A1 (de) | Phytochinoid mit der bezeichnung jacaranon | |
| DE60133138T2 (de) | (-)-olivil als antioxidationsmittel | |
| DE10014674B4 (de) | Verfahren für die Extraktion und Isolierung von Phyllanthin | |
| DE2536399A1 (de) | 2',3'-dihydroestra-1,3,5(10)- trieno- eckige klammer auf 16alpha, 17alpha-b eckige klammer zu- furan- 17beta-ole | |
| DE2350359C3 (de) | Arzneimittel mit einem Gehalt an trans-lsoasaron | |
| DE1145175B (de) | Verfahren zur Gewinnung von Rescidin aus Pflanzen der Rauwolfiaarten und zur Herstellung von dessen Salzen | |
| KR810000644B1 (ko) | 꿀풀과 식물에서 약학적 유효물질을 분리하는 방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8125 | Change of the main classification |
Ipc: C07D303/12 |
|
| 8125 | Change of the main classification |
Ipc: C07D311/78 |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition |